Revision deformity surgery represents one of the most challenging domains in adult spine surgery, with documented complication rates of 40-60% across major series. The incidence of revision surgery has increased with greater numbers of primary adult deformity corrections being performed, improved patient longevity, and heightened expectations for quality of life.

Epidemiology (global):

• Revision rates after primary adult deformity surgery range from 15-30% at 5 years across international multicentre series (ISSG, European Spine Study Group)
• Mean time to revision is 2-3 years, though can range from months to decades
• Patient age at revision typically 55-75 years (older than primary surgery cohort)
• Rising volume worldwide reflects ageing populations, more index deformity corrections, and higher patient expectations

Primary Indications for Revision:

• Pseudarthrosis (35-40%): Most common indication, particularly at lumbosacral junction
• Proximal junctional kyphosis (25-30%): Increasingly recognized complication
• Sagittal imbalance (20-25%): Undercorrection or loss of correction
• Infection (10-15%): May present acutely or as late chronic infection

Practice Context: Complex revision deformity surgery is concentrated worldwide at tertiary spine centres with multidisciplinary support, advanced neuromonitoring, and intensive care. International registries and study groups (Scoliosis Research Society Morbidity & Mortality database, International Spine Study Group, European Spine Study Group) provide the benchmark complication and revision-rate data used for counselling.

Pathophysiology of Deformity Recurrence

Mechanical Failure Mechanisms:

1. Pseudarthrosis (35-40% of Revisions):

   • Incomplete osseous bridging leads to ongoing motion
   • Micromotion prevents bone healing
   • Results in progressive deformity and hardware failure
   • Most common at lumbosacral junction and three-column osteotomy sites

2. Proximal Junctional Kyphosis/Failure (25-30%):

   • Acute angular kyphosis at UIV or UIV+1
   • Caused by stress concentration at construct terminus
   • Biomechanical mismatch between rigid construct and mobile spine
   • Osteoporotic compression fractures at junctional vertebrae

3. Sagittal Imbalance (20-25%):

   • Undercorrection at index surgery
   • Loss of correction over time
   • Progressive adjacent segment degeneration
   • Leads to positive sagittal vertical axis (SVA greater than 50mm)

4. Distal Junctional Failure:

   • Less common than PJK (approximately 5-10%)
   • Typically at lumbosacral junction
   • Inadequate sacropelvic fixation
   • S1 screw pullout or rod fracture

Biological Failure Mechanisms:

Infection:

• Disrupts fusion biology
• Creates biofilm on implants
• Requires staged revision in most cases
• May present as persistent pain or delayed wound healing

Osteoporosis:

• Screw loosening and pullout
• Compression fractures at junctional vertebrae
• Impaired fusion biology
• Higher pseudarthrosis rates

Medical Comorbidities:

• Diabetes impairs wound healing and fusion
• Smoking profoundly inhibits fusion (3-5 fold increased pseudarthrosis)
• Obesity increases mechanical stress on construct
• Malnutrition impairs healing

Anatomical Considerations in Revision Surgery

Scar Tissue and Epidural Adhesions:

• Extensive scar from prior surgery
• Neural elements adherent to dura and bone
• Risk of durotomy increased (10-15% in revisions)
• Risk of nerve injury during dissection

Altered Anatomy:

• Facets and posterior elements may be removed
• Pedicles violated by prior screws
• Bone quality compromised by prior decortication
• Vascular anatomy distorted by scarring

Loss of Fixation Points:

• Previous screw trajectories limit new screw placement
• Osteoporotic bone from stress shielding
• May require alternative fixation (hooks, sublaminar wires, iliac screws)

Revision Complexity Classification (Kim et al.)

Etiology-Based Classification

Mechanical Failures:

• Type A: Pseudarthrosis (most common)
• Type B: Proximal junctional failure
• Type C: Distal junctional failure
• Type D: Hardware failure (rod fracture, screw breakage)

Alignment Failures:

• Type E: Sagittal imbalance (positive SVA)
• Type F: Coronal imbalance (trunk shift)
• Type G: Combined sagittal and coronal imbalance

Biological Failures:

• Type H: Infection (acute or chronic)
• Type I: Implant-related complications (prominence, pain)

Combined Failures:

• Type J: Multiple concurrent failure mechanisms (common in revisions)

Proximal Junctional Kyphosis (PJK) Classification

Hart et al. Classification:

• Type 1: Bony failure (compression fracture at UIV or UIV+1)
• Type 2: Ligamentous failure (disruption of PLL, supraspinous ligament)
• Type 3: Combined bony and ligamentous failure

Clinical Severity:

• Asymptomatic PJK: Greater than 10 degrees but no pain or dysfunction
• Symptomatic PJK: Pain limiting function
• PJF (Proximal Junctional Failure): Neurological deficit or severe deformity requiring revision

History

Timeline of Symptoms:

• Early Recurrence (Less than 6 months): Suggests technical error, infection, or inadequate correction
• Intermediate (6 months to 2 years): Typical for pseudarthrosis or junctional failure
• Late (Greater than 2 years): Adjacent segment disease, late infection, hardware fatigue

Pain Patterns:

• Mechanical Back Pain: Worse with activity, better with rest (pseudarthrosis, hardware failure)
• Radicular Pain: Nerve root compression from deformity or foraminal stenosis
• Neurogenic Claudication: Spinal canal stenosis in deformity
• Constant Pain: Consider infection, especially if night pain

Functional Impact:

• Inability to stand upright (positive sagittal balance)
• Gait disturbance (stooped forward posture, compensatory knee flexion)
• Loss of horizontal gaze (cannot see ahead when walking)
• Decreased walking tolerance and distance
• Impact on activities of daily living

Red Flags:

• Fever, chills, night sweats (infection)
• Progressive neurological deficit
• Bladder or bowel dysfunction
• Rapid deformity progression
• Wound drainage or breakdown

Physical Examination

Global Alignment Assessment:

• Plumb Line Test: C7 plumb line to sacrum (SVA measurement)
• Coronal Balance: C7 plumb line to CSVL (coronal vertical axis)
• Compensatory Mechanisms: Knee flexion, ankle dorsiflexion, pelvic retroversion
• Horizontal Gaze: Can patient look straight ahead when standing?

Local Examination:

• Inspect incision for healing, drainage, erythema
• Palpate for tenderness, fluid collection, implant prominence
• Assess paraspinal muscle bulk (atrophy suggests denervation)
• Check for gibbus or step-off deformity

Neurological Examination:

• Motor strength (all myotomes L2-S2)
• Sensory examination (light touch, pinprick all dermatomes)
• Reflexes (knee, ankle, Babinski)
• Gait assessment (antalgic, Trendelenburg, foot drop)
• Upper motor neuron signs if myelopathy suspected

Functional Assessment:

• Walking distance and speed
• Sit-to-stand test
• Ability to maintain upright posture
• ODI (Oswestry Disability Index) or SRS-22 scores

Differential Diagnosis

Radiographic Assessment

Standing Full-Length Spine Radiographs (Mandatory):

• AP and Lateral: Must be standing weight-bearing to assess true deformity
• Coronal Parameters: Cobb angle, coronal vertical axis (CVA), trunk shift
• Sagittal Parameters:
  • SVA (sagittal vertical axis): C7 plumb line to posterior-superior S1 (normal less than 50mm)
  • Pelvic incidence (PI): Fixed anatomic parameter
  • Lumbar lordosis (LL): L1-S1 Cobb angle
  • PI-LL mismatch: Normal within 10 degrees
  • Pelvic tilt (PT): Compensatory mechanism (normal less than 20 degrees)
  • Thoracic kyphosis (TK): T5-T12 Cobb angle

Hardware Assessment:

• Screw position and haloing (greater than 1mm lucency = loosening)
• Rod integrity (fractures, breakage)
• Connector and cross-link integrity
• Proximal and distal junctional vertebrae assessment

Flexion-Extension Views (Selected Cases):

• Assess for motion at suspected pseudarthrosis
• Greater than 5 degrees motion suggests non-union
• Limited value if hardware intact

Advanced Imaging

CT Scan with Metal Artifact Reduction:

• Gold Standard for Fusion Assessment
• Multiplanar reconstructions (sagittal, coronal, axial)
• Assess each interspace: bridging bone, bone quality
• Greater than 50% bridging bone = solid fusion
• Evaluate screw trajectories for revision planning
• Hounsfield units for bone density assessment

MRI (Selected Indications):

• Infection Suspected: Fluid collections, marrow edema, discitis
• Neurological Symptoms: Neural compression, epidural hematoma
• Soft Tissue Assessment: Muscle atrophy, paraspinal masses
• Use MARS (metal artifact reduction sequences) protocols

Nuclear Medicine:

• SPECT-CT: Functional assessment of fusion
  • Hot spots indicate active stress or non-union
  • Useful when CT equivocal
• Labeled WBC Scan: Infection diagnosis (sensitivity 85-90%)
• PET-CT: Infection or oncologic concerns

Bone Density Assessment:

• DEXA Scan: Essential for all revision candidates
• T-score less than -2.5 indicates osteoporosis
• Adjust surgical plan based on bone quality
• Consider teriparatide pretreatment if severe

Laboratory Evaluation

Baseline Studies:

• CBC: Anemia (blood loss risk), leukocytosis (infection)
• CMP: Renal function (contrast studies), electrolytes
• Coagulation Studies: Baseline for major surgery
• Type and Screen: Anticipate transfusion needs

Infection Workup (If Suspected):

• CRP and ESR: Elevated suggests infection (CRP greater than 10 mg/L)
• Blood Cultures: If systemic sepsis suspected
• Aspiration: Cell count, culture, sensitivity
  • Greater than 3000 WBCs with greater than 80% PMNs suggests infection
  • Send for aerobic, anaerobic, fungal cultures

Bone Health and Nutrition:

• Vitamin D: Target greater than 30 ng/mL
• Calcium, PTH: Assess calcium metabolism
• Albumin, Prealbumin: Nutritional status (albumin greater than 3.5 g/dL)
• HbA1c: Glycemic control (target less than 7.0%)

Specialized Tests:

• Teriparatide Level: If considering anabolic therapy
• Bone Turnover Markers: Assess bone metabolism (research setting)

Non-Operative Management

Indications for Conservative Treatment:

• Medical comorbidities prohibitive for surgery
• Frail patients with limited life expectancy
• Patient preference after informed discussion
• Asymptomatic radiographic findings (incidental PJK, asymptomatic pseudarthrosis)
• Mild symptoms manageable conservatively

Conservative Management Strategies:

Bracing:

• TLSO: For mechanical back pain, pseudarthrosis
• Limited efficacy in adult deformity (poor compliance)
• May temporize symptoms while optimizing for surgery
• Custom-molded braces for better fit in deformed spine

Pain Management:

• Multimodal Analgesia: Acetaminophen, NSAIDs (if renal function allows)
• Neuropathic Agents: Gabapentin, pregabalin for radicular pain
• Muscle Relaxants: Short-term for spasm
• Avoid Long-Term Opioids: Risk of dependence, minimal long-term benefit
• Interventional Pain: Epidural injections, radiofrequency ablation (limited role)

Physical Therapy:

• Core strengthening to unload spine
• Gait training and assistive devices
• Postural exercises (limited effectiveness in fixed deformity)
• Aquatic therapy (buoyancy reduces spinal load)

Lifestyle Modifications:

• Activity modification (avoid prolonged standing, heavy lifting)
• Weight optimization (reduce mechanical load)
• Assistive devices (walker, cane for balance and unloading)

Expected Outcomes:

• Approximately 20-30% achieve acceptable symptom control
• Most patients with significant deformity eventually require surgery
• Conservative management buys time for optimization

Preoperative Optimization

Medical Optimization (Critical for Success):

Bone Health:

• Vitamin D supplementation (target greater than 30 ng/mL, ideally greater than 40)
• Calcium 1500mg daily
• Osteoporosis Treatment:
  • Bisphosphonates: Controversial (may impair fusion, stop 3 months preop)
  • Teriparatide: Anabolic agent, excellent for fusion augmentation
  • Start 3-6 months preoperatively if possible
  • Continue 6-12 months postoperatively

Nutritional Optimization:

• Albumin greater than 3.5 g/dL (target greater than 4.0)
• Consider nutritional supplementation if malnourished
• Protein 1.5 g/kg/day for bone healing

Smoking Cessation:

• Absolute Requirement: Minimum 6 weeks, ideally 3 months
• Increases pseudarthrosis risk 3-5 fold if continued
• Consider nicotine replacement therapy
• Verify with serum cotinine levels

Glycemic Control:

• HbA1c less than 7.0% (target less than 6.5%)
• Infection risk increased with poor control
• Coordinate with endocrinology

Weight Optimization:

• BMI less than 35 preferred (less than 40 acceptable)
• Weight loss reduces surgical risk and mechanical stress
• May require bariatric surgery consultation

Psychosocial Optimization:

• Assess expectations (often unrealistic in revision setting)
• Screen for depression and anxiety (common after failed surgery)
• Ensure social support for prolonged recovery
• Consider psychology clearance for complex cases

Infection Prevention:

• MRSA Screening and Decolonization: Nasal swab, mupirocin ointment
• Chlorhexidine body wash 3 days preoperatively
• Dental evaluation (eradicate oral infection sources)

Operative Management

Surgical Planning Principles:

1. Define Objectives:

   • Achieve solid fusion
   • Restore sagittal and coronal balance
   • Decompress neural elements if indicated
   • Create durable construct

2. Choose Appropriate Technique:

   • Match complexity to failure mechanism
   • Consider patient factors (age, bone quality, comorbidities)
   • Balance risk versus benefit

3. Staged vs Single-Stage:

   • Single-Stage: Most revisions if medically fit
   • Staged: Infection (explant then reconstruct), ultra-complex cases, medical fragility

Surgical Techniques by Indication:

Advanced Surgical Techniques:

Osteotomy Selection:

• Smith-Petersen Osteotomy (SPO):

  • Posterior column release (facets, ligamentum flavum)
  • Correction: 10 degrees per level (flexible deformity)
  • Multiple levels for gradual correction
  • Lower neurological risk than PSO

• Pedicle Subtraction Osteotomy (PSO):

  • Three-column osteotomy through single posterior approach
  • Correction: 30-40 degrees per level
  • Indicated for rigid flatback deformity
  • Higher neurological risk (5-10%)
  • Requires robust fixation (dual rods, extension 3-4 levels each side)

• Vertebral Column Resection (VCR):

  • Complete vertebrectomy (all three columns)
  • Maximum correction potential (50-70 degrees)
  • Reserved for severe rigid deformity, ultra-complex revisions
  • Highest neurological risk (10-20%)
  • Requires ICU monitoring, neuromonitoring, experienced team

Fixation Strategies:

Screw Placement in Revision:

• New Trajectories: Angle screws to avoid prior screw tracks
• Salvage Techniques:
  • Larger diameter screws (6.5mm vs 5.5mm)
  • Longer screws for bicortical purchase
  • Cement augmentation in osteoporotic bone (polymethylmethacrylate)
  • Cortical bone trajectory screws (alternative to pedicle screws)

Supplemental Fixation:

• Hooks: Laminar or pedicle hooks at proximal levels
• Sublaminar Wires: Polyester bands for additional fixation
• Iliac Screws: Mandatory for lumbosacral revisions
• S2-Alar-Iliac (S2AI) Screws: Lower profile alternative to traditional iliac screws

Rod Configuration:

• Dual Rods: Bilateral rods on each side (four rods total)
• Satellite Rods: Supplemental rods to reinforce high-stress zones
• Cobalt-Chromium: Preferred for high-stress constructs (better fatigue resistance)
• Larger Diameter: 6.0mm or 6.35mm (5.5mm inadequate for long revisions)

Biological Augmentation:

• Autograft: Iliac crest or local bone (gold standard)
• Allograft: Structural support, bulk (cancellous chips, DBM)
• BMP-2: Off-label for posterior fusion, 1.5 mg/mL concentration
  • Higher doses increase complications (seroma, ectopic bone)
  • Avoid in anterior cervical spine (swelling risk)
• Bone Marrow Aspirate: Adjunct to autograft/allograft

Neuromonitoring:

• Somatosensory Evoked Potentials (SSEPs): Monitor dorsal column function
• Motor Evoked Potentials (MEPs): Monitor corticospinal tract (more sensitive for motor deficit)
• Triggered EMG: Pedicle screw placement, nerve root monitoring
• Free-Running EMG: Continuous nerve root monitoring during dissection
• Stagnara Wake-Up Test: Backup if neuromonitoring unavailable or questionable changes

Postoperative Management

ICU Care (First 24-48 Hours):

• Neurological checks every 2 hours
• Hemodynamic monitoring (PSO/VCR cases)
• Pain control (epidural, PCA, multimodal)
• Strict I/O monitoring (blood loss replacement)
• Drain management (remove when output less than 50 mL/8 hours)

Early Mobilization (Critical):

• Out of bed to chair POD1 if neurologically intact
• Physical therapy initiated immediately
• Early mobilization reduces complications (DVT, pneumonia, ileus)
• TLSO brace for first 3 months if osteotomy performed

Thromboprophylaxis:

• Mechanical: Sequential compression devices, early mobilization
• Chemical: Enoxaparin or heparin starting POD1 (after drain removal)
• Duration: Minimum 4 weeks, consider extended prophylaxis to 12 weeks

Nutritional Support:

• High-protein diet (1.5 g/kg/day)
• Vitamin D and calcium supplementation
• Consider nutritional consultation if poor intake

Bone Health Continuation:

• Continue teriparatide 12-24 months if started preoperatively
• Vitamin D and calcium indefinitely
• Repeat DEXA at 1-2 years

Surveillance Protocol:

• 2 weeks: Wound check, staple/suture removal, pain assessment
• 6 weeks: Radiographs (AP/Lateral standing full-length), advance PT
• 12 weeks: Radiographs, discontinue brace if appropriate
• 6 months: Radiographs, CT if fusion concern
• 12 months: Radiographs and CT to confirm fusion

Major Complications

Neurological Injury (5-15% in Complex Revisions):

Risk Factors:

• Osteotomy procedures (PSO, VCR)
• Severe deformity correction
• Epidural scarring from prior surgery
• Prolonged retraction

Prevention:

• Multimodal neuromonitoring
• Meticulous technique during dural dissection
• Gradual deformity correction
• Triggered EMG during screw placement
• Maintain mean arterial pressure greater than 85 mmHg

Management:

• Immediate recognition (neuromonitoring changes)
• Release correction if needed
• Wake-up test to confirm
• Urgent MRI if postoperative deficit
• Emergent revision if hematoma or hardware malposition

Infection (8-15% in Revisions):

Risk Factors:

• Diabetes (HbA1c greater than 7.5%)
• Obesity (BMI greater than 35)
• Prolonged surgery (greater than 8 hours)
• Prior infection
• Malnutrition (albumin less than 3.5)

Prevention:

• Preoperative optimization (glycemic control, weight loss)
• Prophylactic antibiotics (cefazolin 2g, redose every 4 hours)
• Meticulous hemostasis and dead space obliteration
• Closed suction drainage
• Negative pressure wound therapy in high-risk cases

Management:

• Early (Less than 3 months): Irrigation and debridement, retain hardware, culture-directed antibiotics 6 weeks IV then 6 weeks PO
• Late (Greater than 3 months): Staged revision (explant, antibiotics 6-12 weeks, reconstruct)
• Biofilm-disrupting antibiotics (rifampin for staphylococci)

Proximal Junctional Kyphosis (20-30% Recurrence After Revision):

Risk Factors:

• Osteoporosis (T-score less than -2.5)
• Overcorrection of lumbar lordosis
• UIV at inflection point (T10-L1)
• Age greater than 65

Prevention:

• Gradual lordosis transition at UIV
• Prophylactic vertebroplasty at UIV and UIV+1
• Extend fusion to upper thoracic (T2-T4) in high-risk cases
• Avoid fusion termination at T10 (extend to T9 or stop at T11)

Management:

• Observation if asymptomatic (kyphosis less than 20 degrees)
• Revision if symptomatic or severe (kyphosis greater than 30 degrees)
• Further cranial extension with osteotomy

Pseudarthrosis (15-30% in Complex Revisions):

Risk Factors:

• Smoking (3-5 fold increased risk)
• Diabetes
• Osteoporosis
• Multilevel revision
• Osteotomy site
• Inadequate biologics

Prevention:

• Smoking cessation (absolute requirement)
• Optimize bone health (vitamin D, teriparatide)
• Generous autograft + BMP
• Robust fixation (extend fixation, dual rods)
• Postoperative immobilization (TLSO 12 weeks)

Management:

• Observation if asymptomatic and no hardware failure
• Revision if symptomatic or hardware failure
• Address all risk factors before re-revision

Medical Complications

Expected Outcomes

Successful Revision:

• Pain Relief: 60-70% achieve significant improvement (greater than 30% reduction in VAS)
• Functional Improvement: 50-60% meaningful improvement in ODI or SRS-22
• Fusion Rate: 70-85% depending on complexity and bone quality
• Patient Satisfaction: 50-65% satisfied or very satisfied (lower than primary surgery)

Radiographic Outcomes:

• SVA Correction: Target SVA less than 50mm achieved in 75-85%
• PI-LL Restoration: Within 10 degrees in 70-80%
• Coronal Balance: CVA less than 30mm in 80-90%

Complication Rates:

• Any Complication: 40-60% (Grade 1-2: 30-40%, Grade 3-4: 10-20%)
• Reoperation: 15-25% within 2 years
• Mortality: 0.5-1% (higher in elderly or ultra-complex cases)

Predictors of Success

Positive Predictors:

• Achievement of solid fusion
• Restoration of sagittal balance (SVA less than 50mm, PI-LL within 10 degrees)
• Younger age (less than 65)
• Good bone quality
• Non-smoker
• Optimal nutritional status
• Single failure mechanism
• First revision (versus multiple prior revisions)

Negative Predictors:

• Multiple prior revisions (greater than 2)
• Active smoking
• Severe osteoporosis (T-score less than -3.0)
• Multiple comorbidities (Charlson Comorbidity Index greater than 3)
• Unrealistic expectations
• Psychological comorbidity (depression, chronic pain syndrome)
• Chronic opioid use preoperatively

Long-Term Outcomes

5-Year Outcomes:

• Fusion rate: 75-85% if first revision
• Adjacent segment disease: 20-30%
• Need for further revision: 20-30%
• Maintained improvement: 60-70% of those initially improved

10-Year Outcomes:

• Limited data due to heterogeneous patient population
• Cumulative revision rate: 30-40%
• Adjacent segment degeneration: 35-45%
• Patient satisfaction maintained: 50-60%

The evidence base in revision deformity surgery is dominated by retrospective cohorts and registry data; few questions have Level I answers. Examiners reward candidates who can articulate the genuine areas of equipoise.

• rhBMP-2 use: Reduces pseudarthrosis and revision odds (Passias 2016) but carries cost, off-label status, and dose-dependent complications (seroma, ectopic bone). Optimal dose and patient selection remain unsettled; use has risen then plateaued, with lower doses over time.
• Bisphosphonates versus anabolics: Teriparatide has Level I support for enhancing fusion (Ebata 2017). Whether perioperative bisphosphonates impair fusion is debated - the older "stop before surgery" dogma is increasingly questioned, but anabolic therapy is preferred when osteoporosis coexists with prior pseudarthrosis.
• Prophylactic vertebroplasty/tethering at the UIV: Reduces proximal junctional failure in some series, but durability, ideal technique (cement vs ligamentous tethers vs hooks), and cost-effectiveness are not established.
• SPO versus PSO for a given correction: Multiple short SPOs can rival a single PSO for moderate flexible deformity with less blood loss; a head-to-head meta-analysis in ankylosing spondylitis found no clear superiority of PSO and flagged rare aortic injury with SPO. Choice remains surgeon- and deformity-specific.
• Single-stage versus staged revision for infection: Acute infection may be managed with debridement and implant retention, but the threshold (commonly cited as under versus over 3 months), the role of biofilm-active agents (rifampicin), and when to stage explantation are not standardized.
• When NOT to operate: There is no validated threshold for prohibitive risk. Frailty indices and the SRS-Schwab/age-adjusted alignment targets help, but the decision to decline revision in the frail, osteoporotic, or chronic-pain patient remains a judgement call - and is itself a high-yield examiner theme.

Global Epidemiology

• Revision after primary adult deformity surgery occurs in 15-30% by 5 years across international multicentre cohorts (ISSG, European Spine Study Group)
• Mechanical failure (rod fracture, PJK/PJF, pseudarthrosis) drives most reoperations; implant-related complications affect roughly one-third of long constructs (Soroceanu 2015)
• Patients are typically 55-75 years, older and frailer than the primary cohort, amplifying medical and bone-quality risk

Side-by-Side Society Guidance

Registry Evidence

• SRS M&M database (108,419 procedures): revision cases carry a 41% higher new-neurological-deficit rate than primary surgery (Hamilton/Smith 2011) - the global benchmark for consent
• National spine registries (British Spine Registry, Scandinavian Swespine, and others) track revision rates, PJK, and patient-reported outcomes, enabling cross-system comparison
• Registry data consistently identify rod fracture, PJK/PJF, and pseudarthrosis as the dominant mechanical reasons for reoperation

High- versus Limited-Resource Practice Variation

• Well-resourced centres: routine multimodal neuromonitoring, cell salvage, ICU, intraoperative imaging/navigation, BMP and anabolic bone agents, staged protocols for infection
• Limited-resource settings: neuromonitoring and ICU may be scarce, shifting practice toward lower-risk techniques (multiple SPOs rather than VCR), the Stagnara wake-up test as a monitoring backup, autograft over costly biologics, and a higher threshold for elective revision
• Across all settings the core principles are constant: define the failure mechanism, optimize the host, restore sagittal balance, secure robust fixation, and know when to decline surgery

• Proximal Junctional Kyphosis: Most common reason for revision deformity surgery
• Pedicle Subtraction Osteotomy: Essential technique for sagittal balance restoration
• Adult Deformity Surgery: Primary procedures that may fail requiring revision
• Pseudarthrosis: Underlying pathology in 35-40% of revisions
• Osteoporosis Management: Critical for preventing fixation failure and PJK
• Spinal Osteotomies: SPO, PSO, VCR techniques for deformity correction
• Rod Fractures: Hardware failure often indicating pseudarthrosis
• Sacropelvic Fixation: Essential for distal junctional failure prevention